Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.

• المؤلفون الرئيسيون: Charoentum C., Thongprasert S., Chewasakulyong B.
• التنسيق: مقال
• اللغة: English
• منشور في: 2014
• الوصول للمادة أونلاين: http://www.scopus.com/inward/record.url?eid=2-s2.0-38449083083&partnerID=40&md5=958bfe0f4532cb224aae8dec2269214c; http://cmuir.cmu.ac.th/handle/6653943832/2143

PURPOSE: To determine the activity and toxicity of combined 24-hour infusion of paclitaxel with carboplatin in advanced non-small cell lung cancer. PATIENTS AND METHODS: Eligibility required measurable disease; stage III B with malignant pleural effusion or stage IV disease, with a performance statu...